Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Obesity | Research

Evaluating the association between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, mental health, and cardio-metabolic risk factors among individuals with obesity

Authors: Abnoos Mokhtari Ardekani, Sahar Vahdat, Ali Hojati, Hadi Moradi, Ayda Zahiri Tousi, Farnoosh Ebrahimzadeh, Mahdieh Abbasalizad Farhangi

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

Several previous investigations have examined the brain-protective role of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet. However, more knowledge is needed about the MIND diet's other favorable impacts. The purpose of this study was to examine the relationship between the MIND diet, mental health, and metabolic markers in individuals with obesity.

Methods

In this cross-sectional study, we included 339 individuals with obesity (BMI ≥ 30 kg/m2) aged 20–50 years. We utilized a semi-quantitative Food Frequency Questionnaire (FFQ), we assessed dietary intake, including 168 food items, and calculated the value of MIND. Metabolic syndrome (MetS) was defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) guidelines. We assessed biochemical parameters using Enzymatic methods. Blood pressure and body composition were also determined.

Results

Higher tertiles of the MIND diet score were associated with significantly higher energy intake, macronutrients, and brain-healthy food intakes (P < 0.001). Among the brain-unhealthy foods, only the intake of sweets and pastries was significantly lower in the highest versus lowest MIND tertiles. We also observed lower odds of stress (P < 0.05) and higher insulin sensitivity (P < 0.05) in the highest versus lowest MIND diet tertiles. We witnessed no significant changes in other parameters.

Conclusion

Lower stress levels and higher insulin sensitivity independent of some confounders like age, BMI, sex, and physical activity were associated with the highest tertile of MIND diet score.
Appendix
Available only for authorised users
Literature
1.
go back to reference James PT, et al. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Prev Cardiol. 2004;11(1):3–8.CrossRef James PT, et al. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Prev Cardiol. 2004;11(1):3–8.CrossRef
2.
go back to reference Van Gaal LF, Mertens IL, Christophe E. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.CrossRef Van Gaal LF, Mertens IL, Christophe E. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.CrossRef
3.
go back to reference Lega IC, Lipscombe LL. Diabetes, obesity, and cancer—pathophysiology and clinical implications. Endocr Rev. 2020;41(1):33–52.CrossRef Lega IC, Lipscombe LL. Diabetes, obesity, and cancer—pathophysiology and clinical implications. Endocr Rev. 2020;41(1):33–52.CrossRef
4.
go back to reference Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.CrossRef Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.CrossRef
5.
go back to reference Keyvanfar A, et al. Association between Sleep Quality and Mental Health among Medical Students in a University Center in Tehran, Iran. Int J Body Mind Cult. 2022;9(1):37–44. Keyvanfar A, et al. Association between Sleep Quality and Mental Health among Medical Students in a University Center in Tehran, Iran. Int J Body Mind Cult. 2022;9(1):37–44.
7.
go back to reference Tang D, et al. Differences in overweight and obesity between the North and South of China. Am J Health Behav. 2020;44(6):780–93.CrossRef Tang D, et al. Differences in overweight and obesity between the North and South of China. Am J Health Behav. 2020;44(6):780–93.CrossRef
8.
go back to reference Valerio A, et al. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet. J Popul Ther Clin Pharmacol. 2020;27(SP1):e31–6.CrossRef Valerio A, et al. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet. J Popul Ther Clin Pharmacol. 2020;27(SP1):e31–6.CrossRef
10.
go back to reference Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001;131(3):871S-873S.CrossRef Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001;131(3):871S-873S.CrossRef
11.
go back to reference Abdollahi SM, et al. The Effectiveness of Solution-Focused Therapy on Life Orientation, Mental Health, and Meaningfulness of Life in Patients with Cardiovascular Diseases. Int J Body Mind Cult. 2020;7(4):238–47. Abdollahi SM, et al. The Effectiveness of Solution-Focused Therapy on Life Orientation, Mental Health, and Meaningfulness of Life in Patients with Cardiovascular Diseases. Int J Body Mind Cult. 2020;7(4):238–47.
12.
go back to reference Aghajani R, et al. Effect of aerobic program in the morning and afternoon on obestatin and the body composition of overweight and obese women. J Chem Health Risks. 2020;10(2):117–25. Aghajani R, et al. Effect of aerobic program in the morning and afternoon on obestatin and the body composition of overweight and obese women. J Chem Health Risks. 2020;10(2):117–25.
13.
go back to reference Jafari-Adli Sh, et al. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord. 2014;13:121–7.CrossRef Jafari-Adli Sh, et al. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord. 2014;13:121–7.CrossRef
14.
go back to reference Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The lancet. 2005;365(9468):1415–28.CrossRef Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The lancet. 2005;365(9468):1415–28.CrossRef
15.
go back to reference Hill JW, Faulkner LD. The Role of the Melanocortin system in metabolic disease: new developments and advances. Neuroendocrinology. 2017;104(4):330–46.CrossRef Hill JW, Faulkner LD. The Role of the Melanocortin system in metabolic disease: new developments and advances. Neuroendocrinology. 2017;104(4):330–46.CrossRef
16.
go back to reference Sayarifard A. et al. Eating Disorders Literacy: Youth’s Beliefs Related to Mental Health First Aid. Int J Body Mind Cult. 2020:214–227. Sayarifard A. et al. Eating Disorders Literacy: Youth’s Beliefs Related to Mental Health First Aid. Int J Body Mind Cult. 2020:214–227.
17.
go back to reference Mallakh MK, Mahmood MM, Ali SHM. Immunomolecular Investigation of Human Papillomavirus Genotypes (16, 18) and P63 Expression in Patients with Malignant and Non-malignant Colorectal Tumors. Arch Razi Inst. 2022;77(1):383–90. Mallakh MK, Mahmood MM, Ali SHM. Immunomolecular Investigation of Human Papillomavirus Genotypes (16, 18) and P63 Expression in Patients with Malignant and Non-malignant Colorectal Tumors. Arch Razi Inst. 2022;77(1):383–90.
18.
go back to reference Yang Y. Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol. 2011;660(1):125–30.CrossRef Yang Y. Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol. 2011;660(1):125–30.CrossRef
19.
go back to reference Hallschmid M, et al. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol Behav. 2004;83(1):55–64.CrossRef Hallschmid M, et al. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol Behav. 2004;83(1):55–64.CrossRef
20.
go back to reference Hess S, et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J Med Chem. 2008;51(4):1026–34.CrossRef Hess S, et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J Med Chem. 2008;51(4):1026–34.CrossRef
21.
go back to reference Yan C, et al. Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. Neuroendocrinology. 2016;103(5):476–88.CrossRef Yan C, et al. Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. Neuroendocrinology. 2016;103(5):476–88.CrossRef
22.
go back to reference Liu T, et al. Action of neurotransmitter: a key to unlock the AgRP neuron feeding circuit. Front Neurosci. 2013;6:200.CrossRef Liu T, et al. Action of neurotransmitter: a key to unlock the AgRP neuron feeding circuit. Front Neurosci. 2013;6:200.CrossRef
23.
go back to reference Katsuki A, et al. Plasma Levels of Agouti-Related Protein Are Increased in Obese Men. J Clin Endocrinol Metab. 2001;86(5):1921–4.CrossRef Katsuki A, et al. Plasma Levels of Agouti-Related Protein Are Increased in Obese Men. J Clin Endocrinol Metab. 2001;86(5):1921–4.CrossRef
24.
go back to reference Lu D, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 1994;371(6500):799–802.CrossRef Lu D, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 1994;371(6500):799–802.CrossRef
25.
go back to reference Lima LB, et al. Relationship of α-MSH and AgRP axons to the perikarya of melanocortin-4 receptor neurons. Brain Res. 2019;1717:1872–6240. Lima LB, et al. Relationship of α-MSH and AgRP axons to the perikarya of melanocortin-4 receptor neurons. Brain Res. 2019;1717:1872–6240.
26.
go back to reference Baltatzi M, et al. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract. 2008;62(9):1432–40.CrossRef Baltatzi M, et al. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract. 2008;62(9):1432–40.CrossRef
27.
go back to reference Katsuki A, et al. Elevated plasma levels of α-melanocyte stimulating hormone (α-MSH) are correlated with insulin resistance in obese men. Int J Obes. 2000;24(10):1260–4.CrossRef Katsuki A, et al. Elevated plasma levels of α-melanocyte stimulating hormone (α-MSH) are correlated with insulin resistance in obese men. Int J Obes. 2000;24(10):1260–4.CrossRef
28.
go back to reference Johansson K, Neovius M, Hemmingsson E. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;99(1):14–23.CrossRef Johansson K, Neovius M, Hemmingsson E. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;99(1):14–23.CrossRef
29.
go back to reference Backus R, Wara A. Development of obesity: Mechanisms and physiology. Vet Clin Small An Pract. 2016;46(5):773–84.CrossRef Backus R, Wara A. Development of obesity: Mechanisms and physiology. Vet Clin Small An Pract. 2016;46(5):773–84.CrossRef
30.
go back to reference Picklo MJ, Thyfault JP. Vitamin E and vitamin C do not reduce insulin sensitivity but inhibit mitochondrial protein expression in exercising obese rats. Appl Physiol Nutr Metab. 2015;40(4):343–52.CrossRef Picklo MJ, Thyfault JP. Vitamin E and vitamin C do not reduce insulin sensitivity but inhibit mitochondrial protein expression in exercising obese rats. Appl Physiol Nutr Metab. 2015;40(4):343–52.CrossRef
31.
go back to reference Brock K, et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol. 2010;121(1–2):462–6.CrossRef Brock K, et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol. 2010;121(1–2):462–6.CrossRef
32.
go back to reference Lu L, et al. Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults. Eur J Nutr. 2020;59(8):3745–53.CrossRef Lu L, et al. Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults. Eur J Nutr. 2020;59(8):3745–53.CrossRef
33.
go back to reference Paradis AM, et al. Associations between dietary patterns and obesity phenotypes. Int J Obes. 2009;33(12):1419–26.CrossRef Paradis AM, et al. Associations between dietary patterns and obesity phenotypes. Int J Obes. 2009;33(12):1419–26.CrossRef
34.
go back to reference Song Y, et al. Secular trends in dietary patterns and obesity-related risk factors in Korean adolescents aged 10–19 years. Int J Obes. 2010;34(1):48–56.CrossRef Song Y, et al. Secular trends in dietary patterns and obesity-related risk factors in Korean adolescents aged 10–19 years. Int J Obes. 2010;34(1):48–56.CrossRef
35.
go back to reference Buckland G, Bach A, Serra-Majem L. Obesity and the Mediterranean diet: a systematic review of observational and intervention studies. Obes Rev. 2008;9(6):582–93.CrossRef Buckland G, Bach A, Serra-Majem L. Obesity and the Mediterranean diet: a systematic review of observational and intervention studies. Obes Rev. 2008;9(6):582–93.CrossRef
36.
go back to reference Panagiotakos DB, et al. Association between the prevalence of obesity and adherence to the Mediterranean diet: the ATTICA study. Nutrition. 2006;22(5):449–56.CrossRef Panagiotakos DB, et al. Association between the prevalence of obesity and adherence to the Mediterranean diet: the ATTICA study. Nutrition. 2006;22(5):449–56.CrossRef
37.
go back to reference Bricarello LP, et al. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: a systematic review. Clin nutr ESPEN. 2018;28:1–11.CrossRef Bricarello LP, et al. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: a systematic review. Clin nutr ESPEN. 2018;28:1–11.CrossRef
38.
go back to reference Ludwig DS. Dietary glycemic index and obesity. J Nutr. 2000;130(2):280S-283S.CrossRef Ludwig DS. Dietary glycemic index and obesity. J Nutr. 2000;130(2):280S-283S.CrossRef
39.
go back to reference Ruiz-Canela M, et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvencion con DIeta MEDiterranea) trial. Br J Nutr. 2015;113(6):984–95.CrossRef Ruiz-Canela M, et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvencion con DIeta MEDiterranea) trial. Br J Nutr. 2015;113(6):984–95.CrossRef
40.
go back to reference Corley J. Adherence to the MIND diet is associated with 12-year all-cause mortality in older adults. Public Health Nutr. 2022;25(2):358-67. Corley J. Adherence to the MIND diet is associated with 12-year all-cause mortality in older adults. Public Health Nutr. 2022;25(2):358-67.
41.
go back to reference Arjmand G, Abbas-Zadeh M, Eftekhari MH. Effect of MIND diet intervention on cognitive performance and brain structure in healthy obese women: a randomized controlled trial. Scientific Reports. 2022;12(1):2871-81. Arjmand G, Abbas-Zadeh M, Eftekhari MH. Effect of MIND diet intervention on cognitive performance and brain structure in healthy obese women: a randomized controlled trial. Scientific Reports. 2022;12(1):2871-81.
42.
go back to reference Koch M, Jensen MK. Association of the MIND diet with cognition and risk of Alzheimer’s disease. Curr Opin Lipidol. 2016;27(3):303–4.CrossRef Koch M, Jensen MK. Association of the MIND diet with cognition and risk of Alzheimer’s disease. Curr Opin Lipidol. 2016;27(3):303–4.CrossRef
43.
go back to reference Morris MC, et al. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015;11(9):1007–14.CrossRef Morris MC, et al. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015;11(9):1007–14.CrossRef
44.
go back to reference Agarwal P, et al. MIND diet associated with reduced incidence and delayed progression of Parkinsonism in old age. J Nutr Health Aging. 2018;22(10):1211–5.CrossRef Agarwal P, et al. MIND diet associated with reduced incidence and delayed progression of Parkinsonism in old age. J Nutr Health Aging. 2018;22(10):1211–5.CrossRef
45.
go back to reference Metcalfe-Roach A, et al. MIND and mediterranean diets associated with later onset of Parkinson’s disease. Mov Disord. 2021;36(4):977–84.CrossRef Metcalfe-Roach A, et al. MIND and mediterranean diets associated with later onset of Parkinson’s disease. Mov Disord. 2021;36(4):977–84.CrossRef
46.
go back to reference Morris MC, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015–22.CrossRef Morris MC, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015–22.CrossRef
47.
go back to reference Bavari F, et al. The effect of bioenergy economy on cardiac function and inflammatory factors in myocardial infarction: A randomized controlled trial. Int J Body Mind Cult. 2022;9(2):129-39. Bavari F, et al. The effect of bioenergy economy on cardiac function and inflammatory factors in myocardial infarction: A randomized controlled trial. Int J Body Mind Cult. 2022;9(2):129-39.
48.
go back to reference Daurbekov TG, et al. Features of the Organization of Activities in the Field of Prevention of Cardiovascular Disease. J Comp Med Res. 2022;13(1):49–52. Daurbekov TG, et al. Features of the Organization of Activities in the Field of Prevention of Cardiovascular Disease. J Comp Med Res. 2022;13(1):49–52.
49.
go back to reference Aminianfar A, et al. Association between adherence to MIND diet and general and abdominal obesity: a cross-sectional study. Nutr J. 2020;19(1):1–9.CrossRef Aminianfar A, et al. Association between adherence to MIND diet and general and abdominal obesity: a cross-sectional study. Nutr J. 2020;19(1):1–9.CrossRef
50.
go back to reference Mohammadpour S, et al. Associations between adherence to MIND diet and metabolic syndrome and general and abdominal obesity: a cross-sectional study. Diabetol Metab Syndr. 2020;12(1):1–10.CrossRef Mohammadpour S, et al. Associations between adherence to MIND diet and metabolic syndrome and general and abdominal obesity: a cross-sectional study. Diabetol Metab Syndr. 2020;12(1):1–10.CrossRef
51.
go back to reference Walker ME, et al. Associations of the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay diet with cardiac remodelling in the community: the Framingham Heart Study. Br J Nutr. 2021;126(12):1888–96.CrossRef Walker ME, et al. Associations of the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay diet with cardiac remodelling in the community: the Framingham Heart Study. Br J Nutr. 2021;126(12):1888–96.CrossRef
52.
go back to reference Abbasalizad Farhangi M, et al. Interaction between Vascular Endothelial Growth Factor-A (rs2010963) Gene Polymorphisms and Dietary Diversity Score on Cardiovascular Risk Factors in Patients with Metabolic Syndrome. Lifestyle Genomics. 2020;13(1):1–10.CrossRef Abbasalizad Farhangi M, et al. Interaction between Vascular Endothelial Growth Factor-A (rs2010963) Gene Polymorphisms and Dietary Diversity Score on Cardiovascular Risk Factors in Patients with Metabolic Syndrome. Lifestyle Genomics. 2020;13(1):1–10.CrossRef
53.
go back to reference Abbasalizad Farhangi M, et al. The interaction between dietary inflammatory index and 6 P21 rs2010963 gene variants in metabolic syndrome. Eat Weight Disord. 2020;25(4):1049–60.CrossRef Abbasalizad Farhangi M, et al. The interaction between dietary inflammatory index and 6 P21 rs2010963 gene variants in metabolic syndrome. Eat Weight Disord. 2020;25(4):1049–60.CrossRef
54.
go back to reference Khodarahmi M, Asghari-Jafarabadi M, Abbasalizad Farhangi M. A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals. PloS One. 2019;14(7):e0219193.CrossRef Khodarahmi M, Asghari-Jafarabadi M, Abbasalizad Farhangi M. A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals. PloS One. 2019;14(7):e0219193.CrossRef
56.
go back to reference Vasheghani-Farahani A, et al. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian J Sports Med. 2011;2(2):106–16.CrossRef Vasheghani-Farahani A, et al. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian J Sports Med. 2011;2(2):106–16.CrossRef
57.
go back to reference Guerra ZC, et al. Associations of acculturation and gender with obesity and physical activity among Latinos. Am J Health Behav. 2022;46(3):324–36.CrossRef Guerra ZC, et al. Associations of acculturation and gender with obesity and physical activity among Latinos. Am J Health Behav. 2022;46(3):324–36.CrossRef
58.
go back to reference Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52.CrossRef Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52.CrossRef
59.
go back to reference Mirmiran P, et al. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.CrossRef Mirmiran P, et al. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.CrossRef
60.
go back to reference Samani S. and B. Jokar: Validity and reliability short-form version of the Depression, Anxiety and Stress; 2001. Samani S. and B. Jokar: Validity and reliability short-form version of the Depression, Anxiety and Stress; 2001.
61.
go back to reference Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. 2005. Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. 2005.
62.
go back to reference Zeng S, Li L. Analysis and Countermeasures of related factors between mental health and physical exercise of Law College Students. Rev de Psicol del Deporte (J Sport Psychol). 2022;31(1):17–25. Zeng S, Li L. Analysis and Countermeasures of related factors between mental health and physical exercise of Law College Students. Rev de Psicol del Deporte (J Sport Psychol). 2022;31(1):17–25.
63.
go back to reference Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.CrossRef Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.CrossRef
64.
go back to reference Szapary PO, et al. Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome. Arterioscler Thromb Vasc Biol. 2006;26(1):182–8.CrossRef Szapary PO, et al. Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome. Arterioscler Thromb Vasc Biol. 2006;26(1):182–8.CrossRef
65.
go back to reference Rothman KJ, Greenland S, and Lash TL. Modern epidemiology. Vol. 3. 2008: Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia. Rothman KJ, Greenland S, and Lash TL. Modern epidemiology. Vol. 3. 2008: Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia.
66.
go back to reference Rodgers JL, et al. Cardiovascular Risks Associated with Gender and Aging. J Cardiovasc Dev Dis. 2019;6(2):19.CrossRef Rodgers JL, et al. Cardiovascular Risks Associated with Gender and Aging. J Cardiovasc Dev Dis. 2019;6(2):19.CrossRef
67.
go back to reference O’Neil A, et al. Gender/Sex as a Social Determinant of Cardiovascular Risk. Circulation. 2018;137(8):854–64.CrossRef O’Neil A, et al. Gender/Sex as a Social Determinant of Cardiovascular Risk. Circulation. 2018;137(8):854–64.CrossRef
68.
go back to reference Hao Z, et al. Association Between Socioeconomic Status and Prevalence of Cardio-Metabolic Risk Factors: A Cross-Sectional Study on Residents in North China. Front Cardiovas Med. 2022;9:698895. Hao Z, et al. Association Between Socioeconomic Status and Prevalence of Cardio-Metabolic Risk Factors: A Cross-Sectional Study on Residents in North China. Front Cardiovas Med. 2022;9:698895.
69.
go back to reference Blanquet M, et al. Socio-economics status and metabolic syndrome: a meta-analysis. Diabetes Metab Syndr. 2019;13(3):1805–12.CrossRef Blanquet M, et al. Socio-economics status and metabolic syndrome: a meta-analysis. Diabetes Metab Syndr. 2019;13(3):1805–12.CrossRef
70.
go back to reference Skrede T, et al. The prospective association between objectively measured sedentary time, moderate-to-vigorous physical activity and cardiometabolic risk factors in youth: a systematic review and meta-analysis. Obes Rev. 2019;20(1):55–74.CrossRef Skrede T, et al. The prospective association between objectively measured sedentary time, moderate-to-vigorous physical activity and cardiometabolic risk factors in youth: a systematic review and meta-analysis. Obes Rev. 2019;20(1):55–74.CrossRef
71.
go back to reference Zalesin KC, et al. Impact of Obesity on Cardiovascular Disease. Endocrinol Metab Clin North Am. 2008;37(3):663–84.CrossRef Zalesin KC, et al. Impact of Obesity on Cardiovascular Disease. Endocrinol Metab Clin North Am. 2008;37(3):663–84.CrossRef
72.
go back to reference Montano D. Education differences in cardiometabolic risk in England, Scotland and the United States between 1992 and 2019. BMC Cardiovasc Disord. 2022;22:247.CrossRef Montano D. Education differences in cardiometabolic risk in England, Scotland and the United States between 1992 and 2019. BMC Cardiovasc Disord. 2022;22:247.CrossRef
73.
go back to reference Dégano IR, et al. The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass index. Sci Rep. 2017;7(1):12370.CrossRef Dégano IR, et al. The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass index. Sci Rep. 2017;7(1):12370.CrossRef
74.
go back to reference Bales CW, Kraus WE. Caloric restriction: implications for human cardiometabolic health. J Cardiopulm Rehabil Prev. 2013;33(4):201–8.CrossRef Bales CW, Kraus WE. Caloric restriction: implications for human cardiometabolic health. J Cardiopulm Rehabil Prev. 2013;33(4):201–8.CrossRef
75.
go back to reference Shahinfar H, et al. Association of dietary energy density with cardiometabolic risk factors and metabolic syndrome in Tehranian older adults. J Cardiovasc Thorac Res. 2020;12(2):97.CrossRef Shahinfar H, et al. Association of dietary energy density with cardiometabolic risk factors and metabolic syndrome in Tehranian older adults. J Cardiovasc Thorac Res. 2020;12(2):97.CrossRef
76.
go back to reference Kim YS, et al. Relationship between physical activity and general mental health. Prev Med. 2012;55(5):458–63.CrossRef Kim YS, et al. Relationship between physical activity and general mental health. Prev Med. 2012;55(5):458–63.CrossRef
77.
go back to reference Wang S, et al. Poor mental health status and its associations with demographic characteristics and chronic diseases in Chinese elderly. Soc Psychiatry Psychiatr Epidemiol. 2016;51(10):1449–55.CrossRef Wang S, et al. Poor mental health status and its associations with demographic characteristics and chronic diseases in Chinese elderly. Soc Psychiatry Psychiatr Epidemiol. 2016;51(10):1449–55.CrossRef
78.
go back to reference Tavakoli SM, Zarghami E, Behnam-Moradi M. The effect of online medical and psychological consultation on the mental health of pregnant women. Int J Body Mind Cult. 2020;7(2):73–81. Tavakoli SM, Zarghami E, Behnam-Moradi M. The effect of online medical and psychological consultation on the mental health of pregnant women. Int J Body Mind Cult. 2020;7(2):73–81.
79.
go back to reference de Crom TO, et al. MIND diet and the risk of dementia: a population-based study. Alzheimers Res Ther. 2022;14(1):1–10. de Crom TO, et al. MIND diet and the risk of dementia: a population-based study. Alzheimers Res Ther. 2022;14(1):1–10.
80.
go back to reference Berendsen AM, et al. Association of long-term adherence to the mind diet with cognitive function and cognitive decline in American women. J Nutr Health Aging. 2018;22(2):222–9.CrossRef Berendsen AM, et al. Association of long-term adherence to the mind diet with cognitive function and cognitive decline in American women. J Nutr Health Aging. 2018;22(2):222–9.CrossRef
81.
go back to reference Salari-Moghaddam A, et al. Adherence to the MIND diet and prevalence of psychological disorders in adults. J Affect Disord. 2019;256:96–102.CrossRef Salari-Moghaddam A, et al. Adherence to the MIND diet and prevalence of psychological disorders in adults. J Affect Disord. 2019;256:96–102.CrossRef
82.
go back to reference Asemi Z, et al. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial. Nutrition. 2014;30(11–12):1287–93.CrossRef Asemi Z, et al. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial. Nutrition. 2014;30(11–12):1287–93.CrossRef
83.
go back to reference Farhadnejad H, et al. The association of Dietary Approach to Stop Hypertension (DASH) diet with metabolic healthy and metabolic unhealthy obesity phenotypes. Sci Rep. 2019;9(1):1–7.CrossRef Farhadnejad H, et al. The association of Dietary Approach to Stop Hypertension (DASH) diet with metabolic healthy and metabolic unhealthy obesity phenotypes. Sci Rep. 2019;9(1):1–7.CrossRef
84.
go back to reference Ghorabi S, et al. Association between the DASH diet and metabolic syndrome components in Iranian adults. Diabetes Metab Syndr. 2019;13(3):1699–704.CrossRef Ghorabi S, et al. Association between the DASH diet and metabolic syndrome components in Iranian adults. Diabetes Metab Syndr. 2019;13(3):1699–704.CrossRef
85.
go back to reference Tzima N, et al. Mediterranean diet and insulin sensitivity, lipid profile and blood pressure levels, in overweight and obese people; the Attica study. Lipids Health Dis. 2007;6(1):1–7.CrossRef Tzima N, et al. Mediterranean diet and insulin sensitivity, lipid profile and blood pressure levels, in overweight and obese people; the Attica study. Lipids Health Dis. 2007;6(1):1–7.CrossRef
86.
go back to reference Tiong X, et al. The association of the dietary approach to stop hypertension (DASH) diet with blood pressure, glucose and lipid profiles in Malaysian and Philippines populations. Nutr Metab Cardiovasc Dis. 2018;28(8):856–63.CrossRef Tiong X, et al. The association of the dietary approach to stop hypertension (DASH) diet with blood pressure, glucose and lipid profiles in Malaysian and Philippines populations. Nutr Metab Cardiovasc Dis. 2018;28(8):856–63.CrossRef
87.
go back to reference Bédard A, et al. Sex differences in the impact of the Mediterranean diet on cardiovascular risk profile. Br J Nutr. 2012;108(8):1428–34.CrossRef Bédard A, et al. Sex differences in the impact of the Mediterranean diet on cardiovascular risk profile. Br J Nutr. 2012;108(8):1428–34.CrossRef
88.
go back to reference Ding M, et al. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study. Bmj. 2017;356:j1000.CrossRef Ding M, et al. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study. Bmj. 2017;356:j1000.CrossRef
89.
go back to reference Schmidt KA, et al. Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial. Am J Clin Nutr. 2021;114(3):882–92.CrossRef Schmidt KA, et al. Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial. Am J Clin Nutr. 2021;114(3):882–92.CrossRef
90.
go back to reference Sun X, Zemel MB. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr. 2004;134(11):3054–60.CrossRef Sun X, Zemel MB. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in Ap2-agouti transgenic mice. J Nutr. 2004;134(11):3054–60.CrossRef
91.
go back to reference Chong MF-F, Macdonald R, Lovegrove JA. Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr. 2010;104(S3):S28–39.CrossRef Chong MF-F, Macdonald R, Lovegrove JA. Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr. 2010;104(S3):S28–39.CrossRef
92.
go back to reference Alissa EM, Ferns GA. Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr. 2017;57(9):1950–62. Alissa EM, Ferns GA. Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr. 2017;57(9):1950–62.
93.
go back to reference Rottapel RE, Hudson LB, Folta SC. Cardiovascular health and African-American women: A qualitative analysis. Am J Health Behav. 2021;45(4):735–45.CrossRef Rottapel RE, Hudson LB, Folta SC. Cardiovascular health and African-American women: A qualitative analysis. Am J Health Behav. 2021;45(4):735–45.CrossRef
94.
go back to reference Haghighian Roudsari A, et al. Psycho-Socio-Cultural Determinants of Food Choice: A Qualitative Study on Adults in Social and Cultural Context of Iran. Iran J Psychiatry. 2017;12(4):241–50. Haghighian Roudsari A, et al. Psycho-Socio-Cultural Determinants of Food Choice: A Qualitative Study on Adults in Social and Cultural Context of Iran. Iran J Psychiatry. 2017;12(4):241–50.
95.
go back to reference Martinez-Zuniga SM. Cultural factors affecting food preference: the case of tarwi in three Quechua speaking areas of Peru. 2007. Martinez-Zuniga SM. Cultural factors affecting food preference: the case of tarwi in three Quechua speaking areas of Peru. 2007.
96.
go back to reference Sobhani SR, et al. Shifting to a Sustainable Dietary Pattern in Iranian Population: Current Evidence and Future Directions. Front Nutr. 2021;8:789692.CrossRef Sobhani SR, et al. Shifting to a Sustainable Dietary Pattern in Iranian Population: Current Evidence and Future Directions. Front Nutr. 2021;8:789692.CrossRef
97.
go back to reference Yazdi-Feyzabadi V, et al. Determinants of risky sexual practice, drug abuse and alcohol consumption in adolescents in Iran: a systematic literature review. Reprod Health. 2019;16(1):115.CrossRef Yazdi-Feyzabadi V, et al. Determinants of risky sexual practice, drug abuse and alcohol consumption in adolescents in Iran: a systematic literature review. Reprod Health. 2019;16(1):115.CrossRef
Metadata
Title
Evaluating the association between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, mental health, and cardio-metabolic risk factors among individuals with obesity
Authors
Abnoos Mokhtari Ardekani
Sahar Vahdat
Ali Hojati
Hadi Moradi
Ayda Zahiri Tousi
Farnoosh Ebrahimzadeh
Mahdieh Abbasalizad Farhangi
Publication date
01-12-2023
Publisher
BioMed Central
Keywords
Obesity
Obesity
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01284-8

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine